Moderna | MRNA - Stock



Moderna reported $240M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Acadia Pharmaceuticals USD 26.12M 3.18M Jun/2025
Adcock Ingram Holdings ZAR 2.54B 136.46M Jun/2024
Agios Pharmaceuticals USD 30.85M 1.24M Jun/2025
Alnylam Pharmaceuticals USD 71.69M 6.11M Jun/2025
Amgen USD 6.58B 146M Jun/2025
Arrowhead Research USD -173085000 173.08M Dec/2024
Biogen USD 2.27B 400K Jun/2025
BioMarin Pharmaceutical USD 1.34B 65.32M Jun/2025
Celltrion KRW 2.83T 2.73T Mar/2025
Cspc Pharmaceutical CNY 3.13B 328.77M Dec/2024
Divis Laboratories Ltd 32.36B 910M Mar/2025
Gilead Sciences USD 1.83B 66M Jun/2025
GlaxoSmithKline GBP 6.07B 72M Jun/2025
Incyte USD 83.42M 19.45M Jun/2025
Ionis Pharmaceuticals USD 8.48M 3.02M Jun/2025
Kangmei Pharma 2.89B 80.05M Sep/2024
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma 327.67M 2.28M Jun/2025
Moderna USD 240M 112M Jun/2025
Organigram Holdings CAD 125.19M 21.23M Jun/2025
Pharma Mar 49.5M 1.02M Jun/2025
Qiagen NV USD 292.55M 11.19M Jun/2025
Regeneron Pharmaceuticals USD 3.21B 760.7M Jun/2025
Sarepta Therapeutics USD 994.04M 52.6M Jun/2025
Sartorius EUR 797.4M 9.5M Jun/2025
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Tilray USD 266.01M 1.71M Nov/2024
Ultragenyx Pharmaceutical USD 46.5M 467K Jun/2025
United Therapeutics USD 169.2M 3.8M Jun/2025
Vertex Pharmaceuticals USD 1.5B 139.6M Jun/2025
Zz Pientze Pharmaceu 4.95B 21.49M Mar/2025